Allogeneic CAR iNKT Cells Induce Host CD8 T-Cell Antitumor Responses

12.02.21

Allogeneic CAR iNKT Cells Induce Host CD8 T-Cell Antitumor Responses

by ASTCT Abstracts

MSLN Directed CAR T-Cell Therapy in AML

11.30.21

MSLN Directed CAR T-Cell Therapy in AML

by ASTCT Abstracts

Auto-HCT Outcome in Older CR1 AML Patients

11.25.21

Auto-HCT Outcome in Older CR1 AML Patients

by ASTCT Abstracts

Type 1 IFN Feasibility in Peri-HCT Period

11.23.21

Type 1 IFN Feasibility in Peri-HCT Period

by ASTCT Abstracts

CAR T Therapy, BiTES Key to “Spectacular” Progress Against R/R DLBCL

11.19.21

CAR T Therapy, BiTES Key to “Spectacular” Progress Against R/R DLBCL

by ASTCT

Rapamycin Pretreatment of EpCAM CAR-T Cells

11.18.21

Rapamycin Pretreatment of EpCAM CAR-T Cells

by ASTCT Abstracts

Donor Macrophage MHC II Role in CNS cGVHD

11.16.21

Donor Macrophage MHC II Role in CNS cGVHD

by ASTCT Abstracts

Review Authors Advocate Greater Use of Single-Arm Trials to Speed Development of Novel Treatment Modalities for Adult ALL

11.15.21

Review Authors Advocate Greater Use of Single-Arm Trials to Speed Development of Novel Treatment Modalities for Adult ALL

by ASTCT

MRD Predicts PFS, OS in Multiple Myeloma Following Stem Cell Transplant in Phase 3 Trial

11.12.21

MRD Predicts PFS, OS in Multiple Myeloma Following Stem Cell Transplant in Phase 3 Trial

by ASTCT

Theme picker

Thank you to our sponsors

Amgen

pharmacyclics

incyte